How berberine phytosome and optimized cinnamon extract are studied for supporting cholesterol, triglyceride, blood sugar, and blood pressure levels already within a normal range, as part of a balanced lifestyle.
Why It Helps to Look at the Whole Metabolic Picture, Not Just One Number
Cholesterol, triglycerides, blood sugar, and blood pressure don't move in separate lanes. They're connected, and they tend to shift together over time as part of the body's overall metabolic balance. If you're the kind of person who reads their own lab reports and wants to help keep each of those numbers in a healthy range, it makes sense to think about the whole picture rather than fixating on one value at a time.
That's the idea behind SoActive Berberine + Optimized Cinnamon. It's designed to help support cardiometabolic markers already within a healthy range as part of a balanced lifestyle. If you take any medication, talk with your doctor before adding a supplement.
SoActive combines berberine phytosome, a well-absorbed form of berberine, with Cinnulin PF® cinnamon extract, a water-soluble cinnamon extract studied at 500mg daily. Berberine phytosome achieved roughly 10× greater systemic exposure (AUC) than standard berberine HCl in a pharmacokinetic study of 12 healthy volunteers (Petrangolini et al., 2021).
In laboratory and animal studies, berberine has been shown to activate AMPK, a cellular energy sensor studied for its role in lipid and glucose metabolism. These findings apply to the individual ingredients at these doses. SoActive has not been clinically tested as a finished product.*
What's in SoActive and Why
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SoActive Berberine + Optimized Cinnamon is a two-ingredient formula for adults who want to help maintain cholesterol, triglyceride, blood sugar, and blood pressure levels already within a normal range. It pairs 1,100mg of Berbervis® berberine phytosome (Indena S.p.A., European Patent EP3746054A1) with 500mg of Cinnulin PF® cinnamon extract (4P Potentia, US Patent 10,058,579), standardized to Type-A procyanidin polymers with coumarin below 0.1%.
Here's the short version of how each piece is meant to fit. Berberine phytosome is a better-absorbed berberine form: it reached roughly 10× greater systemic exposure than standard berberine HCl in a 12-person pharmacokinetic study (Petrangolini et al., 2021). In laboratory and animal research, berberine has been shown to activate AMPK, a cellular energy sensor studied for its role in lipid and glucose metabolism; human outcome data are still limited.
Cinnulin PF® is a water-soluble cinnamon extract studied at 500mg daily for its role in supporting healthy glucose and blood pressure levels already within a normal range. These findings apply to the individual ingredients at these doses. SoActive has not been clinically tested as a finished product.*
See the evidence ↓
Thinking About Your Metabolic Numbers as a Set, Not a List
If you follow your own bloodwork, you already know these numbers tend to travel together. It's easy to end up treating each one as its own separate project, with its own routine and its own follow-up. Looking at cholesterol, triglycerides, blood sugar, and blood pressure as a connected set, part of your overall metabolic balance, is often a more useful way to think about staying in a healthy range.
You like to stay ahead of things. You get the bloodwork. You pay attention to the trends. You've made the lifestyle changes. What you're usually looking for is a way to help support the whole picture, as part of a balanced approach, rather than chasing one value while the others drift.
You'd rather keep your routine simple. Piling on separate products for each number gets complicated fast. A formula built around two well-studied ingredients, taken as part of a healthy diet and regular activity, is an easier thing to stay consistent with.
The takeaway is simple. Your metabolic markers are connected, so it can help to support them together, as part of a balanced lifestyle, rather than one at a time. If you take any medication, talk with your doctor before adding a supplement.*
How Berberine and Cinnamon Are Studied for Metabolic Support
Both ingredients in SoActive have been studied for their role in supporting healthy metabolic markers. Here's what the research actually shows, and where it's still preliminary.
Berberine and the AMPK Pathway
In laboratory and animal research, berberine has been shown to activate AMPK, a cellular energy sensor studied for its role in lipid and glucose metabolism. Much of what's known about how berberine may influence LDL-receptor turnover, fatty acid handling, and glucose metabolism comes from cell-culture and rodent studies; one human study found berberine's glucose effect was AMPK-independent. Human outcome data are still limited, so the mechanism is best understood as a promising area of study rather than settled human physiology.
On the lipid side, the human evidence is stronger. A systematic review and meta-analysis of 16 randomized clinical trials (2,147 participants) documented that berberine supplementation changed total cholesterol by about 0.47 mmol/L, LDL by about 0.38 mmol/L (roughly 15 mg/dL), and triglycerides by about 0.28 mmol/L (roughly 25 mg/dL), and increased HDL by about 0.08 mmol/L (roughly 3 mg/dL) when used alone (Ju et al., 2018, Phytomedicine).
The authors noted the included trials had high heterogeneity and generally low methodological quality, so the findings should be read with appropriate caution. In laboratory studies, berberine has also been studied for effects on PCSK9, a protein involved in LDL-receptor turnover.
Cinnamon Extract, Blood Sugar, and Blood Pressure
In the Ziegenfuss (2006) trial (n=22, 12 weeks), a small double-blind, placebo-controlled study in pre-diabetic adults, fasting blood glucose fell 8.4% (about 10 mg/dL) in the cinnamon group, and systolic readings in the cinnamon group decreased from 133 to 128 mmHg over the study period (a within-group change in a small study). A separate study using the same cinnamon extract (Roussel et al., 2009, Journal of the American College of Nutrition) reported improved antioxidant status (increased ferric-reducing antioxidant power) and reduced oxidative-stress markers (malondialdehyde) in adults with impaired fasting glucose.
The Two Ingredients Together
A 2025 randomized clinical trial (Mansour et al., European Journal of Nutrition) tested berberine plus cinnamon (1,200mg berberine and 600mg cinnamon daily) against placebo for 12 weeks in adults with type 2 diabetes, and reported lower fasting blood sugar, HbA1c, and LDL cholesterol in the combination group, with no significant difference in total cholesterol, HDL, or triglycerides. These findings apply to the individual ingredients at the doses studied. SoActive has not been clinically tested as a finished product.*
*Here's how the lipid and glucose research fits together. For lipids, the Ju et al. (2018) systematic review and meta-analysis in Phytomedicine synthesized randomized clinical trial data documenting changes in total cholesterol, LDL, and triglycerides and an increase in HDL, while noting high heterogeneity and generally low trial quality. In laboratory and animal research, berberine has been shown to activate AMPK, a cellular energy sensor studied for its role in lipid and glucose metabolism; human outcome data are still limited.
For glucose, Xie et al. (2022; 37 RCTs, n=3,048) found berberine was associated with lower fasting glucose and HbA1c in people with elevated blood sugar; the effect was hyperglycemia-dependent and the trials were mostly conducted in China and of moderate quality. For blood pressure, the Ziegenfuss (2006) trial reported a within-group decrease in systolic readings in a small (n=22) study. These findings apply to the individual ingredients at these doses; SoActive has not been clinically tested as a finished product. If you take any medication, talk with your doctor before adding a supplement.
What Supporting Your Metabolic Numbers Might Look Like
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
These aren't isolated tweaks to separate numbers. The point of supporting the whole picture is that cholesterol, triglycerides, blood sugar, and blood pressure are connected, and small, healthy-range shifts in one often go along with shifts in the others.
Your Cholesterol and Triglyceride Numbers
In the Ju et al. (2018) meta-analysis, berberine supplementation was associated with changes across the lipid profile, total cholesterol (about 0.47 mmol/L), LDL (about 0.38 mmol/L), and triglycerides (about 0.28 mmol/L), and an HDL increase (about 0.08 mmol/L, used alone), across independent study populations, with the caveats about trial quality noted above.*
For someone who tracks their own panel, the appeal is straightforward: an ingredient studied for its role in supporting several lipid numbers at once, as part of a balanced lifestyle, rather than one at a time.
Your Blood Sugar Numbers
Xie et al. (2022; 37 RCTs, n=3,048) found berberine was associated with lower fasting glucose and HbA1c in people with elevated blood sugar; the effect was hyperglycemia-dependent and the trials were mostly conducted in China and of moderate quality. Cinnulin PF® was also studied for glucose support in the Ziegenfuss (2006) trial, where fasting blood glucose fell 8.4% (about 10 mg/dL) over 12 weeks in a small group.*
For someone paying attention to fasting glucose year over year, that's the reason both ingredients are in the formula, to help support blood sugar already within a normal range as part of a balanced lifestyle.
Your Blood Pressure Readings
In the Ziegenfuss (2006) trial (n=22, 12 weeks), systolic readings in the cinnamon group decreased from 133 to 128 mmHg over the study period (a within-group change in a small study). A separate study using the same cinnamon extract (Roussel et al., 2009) reported improved antioxidant status and reduced oxidative-stress markers.*
The reason this matters for the whole-picture approach is that it's one more healthy-range number the formula is designed to help support, as part of a balanced lifestyle, alongside the others.
Body Composition
In the Ziegenfuss (2006) trial (n=22), the cinnamon group showed small within-group changes in lean mass (+1.1%) and body fat (−0.7%) over 12 weeks, alongside diet and exercise. Body-composition support is best thought of as one part of a balanced approach that includes healthy eating and regular activity, not a standalone effect of the supplement.*
The Research Behind the Ingredients
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SoActive draws on published research for its two ingredients. Note that these findings apply to the individual ingredients at the doses studied; SoActive has not been clinically tested as a finished product.*
Study 1, Ju et al. (2018), Lipid Evidence.
Design: systematic review and meta-analysis of 16 randomized clinical trials (2,147 participants). Journal: Phytomedicine (peer-reviewed).
Finding: berberine changed total cholesterol by about 0.47 mmol/L, LDL by about 0.38 mmol/L, and triglycerides by about 0.28 mmol/L, and increased HDL by about 0.08 mmol/L (used alone). The authors noted high heterogeneity and generally low trial quality, advising cautious interpretation.
Attribution: these values represent berberine supplementation outcomes documented in the meta-analysis, not SoActive-specific claims.
Citation: Ju, J., Li, J., Lin, Q., & Xu, H. (2018). Phytomedicine, 50, 25–34. DOI: 10.1016/j.phymed.2018.09.212
Study 2, Petrangolini et al. (2021), Absorption.
Design: pharmacokinetic study, n=12 healthy adults (manufacturer-conducted; industry-funded). Journal: Evidence-Based Complementary and Alternative Medicine.
Finding: berberine phytosome improved berberine bioavailability (AUC) by approximately 10-fold on a molar basis versus unformulated berberine, with dose linearity. This is an absorption study; it did not measure AMPK activity or clinical outcomes.
Citation: Petrangolini, G., Corti, F., Ronchi, M., Arnoldi, L., Allegrini, P., & Riva, A. (2021). Evidence-Based Complementary and Alternative Medicine, 2021, 7563889. DOI: 10.1155/2021/7563889
Study 3, Ziegenfuss et al. (2006), Cinnamon at 500mg/day.
Design: randomized, double-blind, placebo-controlled, n=22 pre-diabetic adults, 12 weeks, 500mg Cinnulin PF®/day.
Finding: fasting blood glucose −8.4% (about −10 mg/dL); systolic readings in the cinnamon group decreased from 133 to 128 mmHg (a within-group change); small within-group changes in lean mass (+1.1%) and body fat (−0.7%).
Citation: Ziegenfuss, T.N., Hofheins, J.E., Mendel, R.W., Landis, J., & Anderson, R.A. (2006). Journal of the International Society of Sports Nutrition, 3(2), 45–53. DOI: 10.1186/1550-2783-3-2-45
Study 4, Roussel et al. (2009), Antioxidant Status With the Same Cinnamon Extract.
Design: randomized, double-blind, placebo-controlled, n=22 adults with impaired fasting glucose (overweight/obese), 12 weeks, 250mg Cinnulin PF® twice daily. Journal: Journal of the American College of Nutrition.
Finding: increased ferric-reducing antioxidant power (FRAP) and plasma thiols, and reduced plasma malondialdehyde (MDA), a marker of oxidative stress.
Citation: Roussel, A.M., Hininger, I., Benaraba, R., Ziegenfuss, T.N., & Anderson, R.A. (2009). Journal of the American College of Nutrition, 28(1), 16–21. DOI: 10.1080/07315724.2009.10719756
Study 5, Xie et al. (2022), Glucose Meta-Analysis (37 RCTs).
Design: systematic review and meta-analysis, 37 RCTs, n=3,048 participants. Journal: Frontiers in Pharmacology (peer-reviewed).
Finding: berberine was associated with lower fasting glucose and HbA1c in people with elevated blood sugar; the effect was hyperglycemia-dependent and the trials were mostly conducted in China and of moderate quality.
Citation: Xie, W., Su, F., Wang, G., Peng, Z., et al. (2022). Frontiers in Pharmacology, 13, 1015045. DOI: 10.3389/fphar.2022.1015045
Study 6, Mansour et al. (2025), Combination in Type 2 Diabetes.
Design: randomized, double-blind, placebo-controlled trial, berberine plus cinnamon (1,200mg berberine and 600mg cinnamon daily) versus placebo, adults with type 2 diabetes, 12 weeks. Journal: European Journal of Nutrition, 64, 102.
Finding: lower fasting blood sugar, HbA1c, and LDL cholesterol versus placebo; no significant difference in total cholesterol, HDL, or triglycerides.
Citation: Mansour, A., Sajjadi-Jazi, S.M., Gerami, H., et al. (2025). European Journal of Nutrition, 64, 102. DOI: 10.1007/s00394-025-03618-9
How SoActive Compares to Other Options
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Here's how SoActive's two studied ingredients stack up against other popular natural options people consider for metabolic support. These are general ingredient comparisons, not head-to-head product tests, and none of them is a substitute for professional medical advice.
When choosing natural support for cholesterol, triglycerides, blood sugar, and blood pressure already within a normal range:
✓ SoActive Berberine + Optimized Cinnamon pairs berberine phytosome (a well-absorbed berberine form with meta-analytic lipid evidence for the ingredient) with a cinnamon extract studied at 500mg daily. It's aimed at people who want to support several metabolic numbers together, as part of a balanced lifestyle.
○ Omega-3 fatty acids (EPA/DHA) are well studied for supporting healthy triglyceride levels already within a normal range through a different mechanism, and can be used alongside SoActive.
○ Plant sterols are studied mainly for LDL; they don't offer the same glucose or blood pressure research.
✗ Use caution with red yeast rice, which contains naturally occurring lovastatin (the same compound class as some prescription drugs) and carries variable potency between products. Talk with your doctor before combining it with any medication.
✗ Use caution with generic single-ingredient options (chromium, plain cinnamon powder, generic niacin), which often aren't standardized to a studied dose.
Common Questions
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Can I take SoActive if I already take medication?
If you take any medication, talk with your doctor or pharmacist before adding a supplement. Berberine can affect the enzymes (CYP3A4, CYP2D6, CYP2C9) and the transporter (P-glycoprotein) that your body uses to process many medications, so a quick professional check is the right first step. Your provider can tell you whether it's appropriate for your situation.*
How long might it take to notice a difference in my numbers?
Research on these ingredients generally runs over 8 to 12 weeks, so it's reasonable to think in terms of a full quarter rather than days. A good approach is to note your baseline fasting numbers before starting, keep the rest of your routine steady, and re-check with your healthcare provider after about 90 days.*
Is SoActive a replacement for any of my medications?
No. SoActive is not a replacement for any prescribed medication and shouldn't be used to stop or change a prescription. It's designed to help support metabolic markers already within a normal range as part of a balanced lifestyle. Always talk with your prescribing physician before making any change to your regimen.*
Can I take SoActive Berberine + Optimized Cinnamon with CoQ10?
There's no known interaction between CoQ10 and the ingredients in SoActive, and the two are often used for different reasons. As with any combination, it's worth reviewing your full supplement list with your physician.*
Does SoActive affect body composition?
Body composition is driven mostly by diet and activity. In the Ziegenfuss (2006) trial, the cinnamon group showed only small within-group changes in lean mass and body fat over 12 weeks, alongside diet and exercise, so it's best to think of any support here as one part of a balanced approach rather than a standalone effect.*
Does berberine interact with warfarin or other blood thinners?
Possibly. Berberine may affect CYP2C9, an enzyme involved in warfarin metabolism. If you take warfarin or any anticoagulant, talk with your anticoagulation management team before starting and plan to monitor more closely. This warrants medical supervision, so don't start without professional input.*
The Bottom Line
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Cholesterol, triglycerides, blood sugar, and blood pressure are connected, so it can help to support them together, as part of a balanced lifestyle, rather than one number at a time. SoActive Berberine + Optimized Cinnamon is built around two well-studied ingredients, a better-absorbed berberine form and a cinnamon extract studied at 500mg daily, for adults who want to help maintain those numbers already within a normal range.
The ingredient research is published and cited above. Just remember that those findings apply to the individual ingredients at the doses studied, and SoActive has not been clinically tested as a finished product. If you take any medication, talk with your doctor before adding a supplement.*
Learn More About SoActive Berberine + Optimized Cinnamon →
Backed by a 60-day satisfaction guarantee and manufactured in an FDA-registered facility under cGMP standards.
This content is educational and does not constitute medical advice.*
For the Detail-Oriented: Ingredient and Safety Documentation
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Full Ingredient Breakdown
Berbervis® Berberine Phytosome, 1,100mg Daily (550mg twice daily with meals)
Berberis aristata + Sunflower Phospholipid + Grape Seed Extract | Patent EP3746054A1 | Indena S.p.A.
- Absorption: roughly 10× greater systemic exposure (AUC) on a molar basis versus standard berberine HCl in a 12-person pharmacokinetic study (Petrangolini et al., 2021). This was an absorption study; it did not measure AMPK activity or clinical outcomes.
- Mechanism (preliminary): in laboratory and animal research, berberine has been shown to activate AMPK, a cellular energy sensor studied for its role in lipid and glucose metabolism. In laboratory studies, berberine has also been studied for effects on PCSK9, a protein involved in LDL-receptor turnover. Human outcome data are still limited.
- Lipid research (ingredient level): the Ju et al. (2018) meta-analysis documented changes in total cholesterol (~0.47 mmol/L), LDL (~0.38 mmol/L, roughly 15 mg/dL), triglycerides (~0.28 mmol/L, roughly 25 mg/dL), and HDL (~0.08 mmol/L, used alone), with the trial-quality caveats noted above.
- GI tolerability: the phytosome formulation was developed to improve tolerability versus standard berberine.
- Drug interaction guidance: berberine inhibits CYP2D6, CYP3A4, and P-glycoprotein. Talk with your doctor or pharmacist before combining with any medication. A brief professional check is the appropriate step.
Cinnulin PF® Cinnamon Extract, 500mg Daily (250mg twice daily with meals)
Cinnamomum cassia bark, proprietary water extraction | Type-A procyanidin polymers | Coumarin <0.1% | Patent US 10,058,579 | 4P Potentia
- Glucose and blood pressure (ingredient level): in the Ziegenfuss (2006) trial (n=22, 12 weeks), fasting blood glucose fell 8.4% (about 10 mg/dL), and systolic readings in the cinnamon group decreased from 133 to 128 mmHg over the study period (a within-group change in a small study).
- Antioxidant status: a separate study using the same extract (Roussel et al., 2009) reported increased ferric-reducing antioxidant power and reduced malondialdehyde.
- Body composition: in Ziegenfuss (2006), small within-group changes in lean mass (+1.1%) and body fat (−0.7%) over 12 weeks, alongside diet and exercise.
- Safety profile: coumarin reduced to below 0.1%. Type-A polymer standardization verified per batch CoA.
Drug Interaction Notes
Berberine and CYP enzymes / P-glycoprotein: berberine can inhibit CYP3A4, CYP2D6, and CYP2C9, and P-glycoprotein, which are involved in processing many medications. Clinical significance varies by drug and by individual. Talk with your doctor or pharmacist before combining SoActive with any prescription.
Anticoagulants (warfarin): berberine may affect warfarin metabolism through CYP2C9; monitor more closely and consult your anticoagulation team before starting.
Blood pressure and diabetes medications: additive effects are possible. Monitor and discuss with your prescribing physician.
General principle: SoActive is not a replacement for any prescribed medication. Always review your complete medication list with your doctor or pharmacist before starting.
Additional Questions
What does the research say about cinnamon and blood pressure specifically?
The most direct evidence is the Ziegenfuss (2006) trial, where systolic readings in the cinnamon group decreased from 133 to 128 mmHg over 12 weeks, a within-group change in a small (n=22) study. Because it's a single small study, it should be read as preliminary rather than definitive.*
Should I track my numbers if I try SoActive?
If you like to follow your own labs, noting your baseline fasting values before starting and re-checking with your healthcare provider after about 90 days is a sensible way to see what's happening. Share the results with your doctor.*
Scientific References & Citations
All sources are independently verifiable through the provided links. Ju et al. (2018) lipid values represent berberine supplementation outcomes documented in the meta-analysis, not SoActive-specific claims.
Ju, J., Li, J., Lin, Q., & Xu, H. (2018). Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials. Phytomedicine, 50, 25–34. DOI: 10.1016/j.phymed.2018.09.212
Mansour, A., Sajjadi-Jazi, S.M., Gerami, H., et al. (2025). The efficacy and safety of berberine in combination with cinnamon supplementation in patients with type 2 diabetes: A randomized clinical trial. European Journal of Nutrition, 64, 102. DOI: 10.1007/s00394-025-03618-9
Petrangolini, G., Corti, F., Ronchi, M., Arnoldi, L., Allegrini, P., & Riva, A. (2021). Development of an innovative berberine food-grade formulation with an ameliorated absorption: In vitro evidence confirmed by healthy volunteers pharmacokinetic study. Evidence-Based Complementary and Alternative Medicine, 2021, 7563889. DOI: 10.1155/2021/7563889
Roussel, A.M., Hininger, I., Benaraba, R., Ziegenfuss, T.N., & Anderson, R.A. (2009). Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. Journal of the American College of Nutrition, 28(1), 16–21. DOI: 10.1080/07315724.2009.10719756
Xie, W., Su, F., Wang, G., Peng, Z., et al. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, 1015045. DOI: 10.3389/fphar.2022.1015045
Ziegenfuss, T.N., Hofheins, J.E., Mendel, R.W., Landis, J., & Anderson, R.A. (2006). Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. Journal of the International Society of Sports Nutrition, 3(2), 45–53. DOI: 10.1186/1550-2783-3-2-45
Regulatory Certifications & Safety Documentation
Indena S.p.A. European Patent EP3746054A1. Berbervis® Berberine Phytosome. Registry: European Patent Office.
4P Potentia. US Patent 10,058,579. Cinnulin PF® Cinnamon Extract. Registry: United States Patent and Trademark Office.
U.S. Food and Drug Administration. GRAS (Generally Recognized as Safe) Notice Inventory.
Manufacturing quality standards: Current Good Manufacturing Practice (cGMP) certification — FDA 21 CFR Part 111 (Dietary Supplement cGMP). FDA-registered manufacturing facility. Certificate of Analysis available per batch.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. If you take any medication, talk with your doctor before adding a supplement. SoActive is not a replacement for any prescribed medication. This content is educational and does not constitute medical advice.
Berbervis® is a registered trademark of Indena S.p.A. (Patent EP3746054A1). Cinnulin PF® is a registered trademark of 4P Potentia (US Patent 10,058,579).
